Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT06230380
Recruiting Not applicable

Autofluorescence in Surgery for Primary Hyperparathyroidism

NCT06230380 · tracked via the Priya Life Science Denmark tracker
Sponsor
Aarhus University Hospital
Phase
Not applicable
Started
2024-01-01
Last updated
2025-01-29

Condition(s) studied

Hyperparathyroidism, Primary

Investigational drug(s) / intervention(s)

Surgery with autofluorescence

Surgery with autofluorescence: In the experimental group, the surgeon will use the EleVision IR camera system (Medtronic, USA) to visualize PTGs during surgery. The surgical field will be visualized with AF as a minimum of two times during surgery on each side of the neck: First upon exposing the undersurface of the thyroid gland, and secondly before removal of a pathological PTG. Also, removed PTGs will be examined ex vivo to document AF pattern.

Study summary

The study aims to test if autofluorescence imaging (AF) is a useful surgical aid during parathyroidectomy (PTX) for primary hyperthyroidism (PHPT).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age\>18 years and able to give informed consent. * A diagnosis of PHPT. * Planned exploratory PTX with ioPTH measurement. Exclusion Criteria: * Concordant high-confidence imaging; planned focused/selective PTX * Previous thyroid or parathyroid surgery. * Planned simultaneous thyroid surgery. * MEN, lithium induced hyperparathyroidism. * eGFR \< 30. * Kidney transplant.

Primary outcome measure(s)

  • Operating time — During surgery
    Time elapsed from skin incision to skin closure in patients who achieve normocalcemia after one operation.

Trial sites (1)

FacilityCityRegionStatus
Aarhus University Hospital Aarhus Denmark Recruiting

More Aarhus University Hospital trials in Denmark

Body Project SMIL: Prevention of Eating Disorders Among Young Women With Psychiatric Illness With the Body Project Starting soon
Assessment of Residual Congestion in Acute Decompensated Heart Failure Recruiting
Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke Recruiting
Progressive Resistance Training for Adults With External Snapping Hip Recruiting
Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06230380 on ClinicalTrials.gov ↗ ← All trials in Denmark